MedPath

T-900607

Generic Name
T-900607
Drug Type
Small Molecule
Chemical Formula
C14H10F5N3O4S
CAS Number
261944-52-9
Unique Ingredient Identifier
IC9O2HT1X1

Overview

T900607 has been used in trials studying the treatment of Liver Cancer and Gastric Cancer.

Background

T900607 has been used in trials studying the treatment of Liver Cancer and Gastric Cancer.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2003/02/06
Phase 2
Completed
University Hospitals Seidman Cancer Center
2003/02/06
Phase 2
Completed
University Hospitals Seidman Cancer Center

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath